Optimization of a Series of Potent, Selective and Orally Bioavailable SYK Inhibitors.
暂无分享，去创建一个
David M. Wilson | Peng-Fei Wang | S. Fawell | W. Shao | J. Patel | N. Grimster | B. Barlaam | U. Sarkar | P. Kemmitt | Qibin Su | S. Kawatkar | R. Tomlinson | T. Ikeda | S. Edmondson | J. Read | Frederick W. Goldberg | Haixia Wang | I. Simpson | A. Pike | J. Dowling | D. Watson | Amber Y. S. Balazs | Xiaolan Zheng | Li Sha | L. Gingipalli | Haiyun Wang | F. Goldberg | Anna C. Impastato | Troy E. Zehnder | Scott Boiko | Scott G. Lamont | Lianghe Wang | H. Dry | Natalie H Jones | Iain Simpson | Peng‐Fei Wang | Natalie H. Jones | Ujjal Sarkar | Sameer Kawatkar